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R116were typically discarded [17]. These
technical advances have inspired the
‘herbalome project’ to intensely focus
on developing new extraction and
purification techniques [2]. Second,
the strategy used in the current study
was to screen fractions on mu-opioid
receptor-expressing cell lines and it
was only fortuitous that DHCB had
weak actions at the mu-opioid
receptor. Other equally efficacious
compounds may have been missed
by the selective nature of the screen.
Additional high-throughput strategies
need to be developed that also
screen compounds for their activity
at presynaptic receptors and
potentially their ability to induce
antinociception.
A remaining question is whether
target-based strategies are useful for
development of new therapeutics. This
strategy has been the predominant one
over the past 20 years and has failed
to develop sufficient new therapeutics
[18]. Reverse pharmacology is
dependent on screening known
receptor structures, even though some
of the receptors are orphan receptors
with no known endogenous ligand.
The pain community has at least
expanded their target-based approach
to include therapeutic development of
ligands that target other proteins,
including ion channels, such as TRPV1
[19], and transporters, such as the
potassium–chloride cotransporter
(KCC2) [20], for analgesia. This field is
currently exploding and it is likely that
natural compounds from TCMs will be
isolated that selectively modulate
these targets as well.References
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Step ForwardThe spindle is a micron-scale structure that assembles from nanometer-sized
tubulin building blocks. How does the spindle know what size to be? Changes
in cytoplasmic volume are shown to be sufficient to modulate the size of the
spindle.Sophie Dumont
Biological assemblies are built from
smaller building blocks. While we have
uncovered the identity of many building
blocks of life, we do not understand
what specifies the size of the structuresthey form. Yet, their size must be
carefully controlled. As kids, we
disappointingly learned that the tallest
snow fort we could build was
determined by our own height, no
matter how much snow had fallen.
Fort height was thus set by our ownintrinsic limitations, not by the
availability of snow building blocks
(in Canada, at least). In contrast, the
biggest LEGO structure we could build
was not limited by us, but by an
extrinsic factor — the number of
available LEGO blocks. What sets the
size of the biological structures
nature builds? New studies by
Good et al. [1] and Hazel et al. [2] show
that changes in cytoplasmic
volume — and likely the number of
building blocks — are sufficient to
regulate the size of a macromolecular
assembly.





Figure 1. Spindle size control.
Good et al. [1] and Hazel et al. [2] use microfluidics to make cell-like droplets of different sizes
containing the same cytoplasm. They show that changes in cytoplasmic volume are sufficient
to regulate spindle size in small droplets. A limited pool of cytoplasmic spindle building blocks
is thought to set spindle size as droplets become smaller.
Dispatch
R117come together to build micron-scale
intracellular structures and cells,
which in turn build tissues and
organisms. With different niches and
functions come different sizes:
organisms range from a micron to
tens of meters in size, cells span a
micron to centimeters in size, and
intracellular structures range from
nanometers to centimeters in
size. We have been fascinated by
the problem of organism size
determination for more than a century
and that of cell size for decades, and
principles of organism and cell size
determination are beginning to
emerge. But how individual molecules
self-assemble into intracellular
structures of specific sizes remains an
open question [3,4]. How does the
scale of macromolecular assemblies
emerge? How do individual
molecules know to assemble into
structures of different sizes?
Although molecular approaches are
revealing the contributions of specific
molecules to size determination, the
contributions of simple physical
parameters — such as the volume and
shape of the cells they reside in— have
been challenging to interrogate. In
large part, this is because physical
parameters are difficult to tune and
control.
The spindle, the machine that
segregates chromosomes at cell
division, is a spectacular example of a
macromolecular machine that must
self-assemble into differently sized
versions of itself. Different organisms
and tissues have cells of different sizes,
and a given organism’s cells can
reduce 100-fold in diameter during
development. Somehow, the spindle
must adapt its size to those of the
dividing cell and the chromosomes
to be segregated. In their early
development, many animal embryos
undergo rapid cell divisions without
growth, and their cells and spindles
become progressively smaller. Why
would spindle size matter? One
possibility is that the spindle may need
to be large enough to handle and
accurately segregate the large
chromosomes found in large,
early-embryo cells (where
chromosomes are often uncondensed
[5]). Yet, in smaller cells the spindle
must be small enough to fit in the
cytoplasm, and a spindle that is too
large may experience structural and
energetic penalties. Spindle size
has been observed to scale with cellsize in frogs [6], worms [7,8] and
mammals [9], but whether cell size
specifies — or simply correlates
with — spindle size is not known.
How do nanometer-sized tubulin
building blocks assemble to form a
spindle of 2, 10 or 50 mm? How does
the cell even know the size of its
spindle?
In principle, spindle size could be
set by the nature of the cytoplasm,
cell volume or cell shape [10,11]. To
probe different models, molecular
tools can help us control cell contents,
but controlling cell volume and cell
shape remain a frontier. In particular,
how is one to control cell volume
without making molecular changes?
Good et al. [1] and Hazel et al. [2]
have developed an approach to do
just that: the idea is simple, and its
implementation a technical tour de
force. Using microfluidic devices to
mix frog egg cytoplasm and oil, they
generate discrete cytoplasm
droplets (cell-like compartments) of
different sizes and ask how their
volume and shape affect spindle size.
Their clever experimental design
gives them a way to directly control
cytoplasmic volume without
perturbing molecules — a big step
forward. Strikingly, the authors find
that spindle size scales with droplet
size just the way it does with cell size
inside frog embryos. As droplet
diameter increases from 20 to 80 mm,
spindle length increases too,
remaining about half the dropletdiameter (Figure 1, left and center
droplets). Thus, changes in
cytoplasm size cause (and don’t
just correlate with) spindle size
changes in this small cell regime. This
is true for mitotic and meiotic
spindles, which have different
architectures, and for different frog
species [1]. Both droplet volume and
boundary positions change with
droplet size, and to disentangle both
contributions the authors change
droplet shape without changing
volume. The data convincingly show
that droplet volume, and not shape,
sets spindle size. We note that
these droplets lack cell cortex
components, and synthetically
introducing these components could
help probe whether cell shape can
control spindle size when cortical
forces are present. Finally, in droplets
larger than 80 mm, spindle length
plateaus at 40–45 mm (Figure 1, center
and right droplets), just as it does in
embryos and unbounded cytoplasm.
Spindle size must be limited — and
set — by something other than
cytoplasmic volume in this large-cell
regime.
How could cytoplasmic volume
set the size of a macromolecular
assembly? In a simple model, a
limited pool of cytoplasmic spindle
building blocks could set spindle
size. In small volumes, materials are
scarce and components become
limited [12]: not only by their absolute
number, as for a LEGO structure, but
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concentration as a higher fraction is
now used up in the spindle. This
lower concentration could push the
chemical equilibrium (mass action)
between free components (reactants)
and spindle-integrated components
(products), producing a smaller
spindle given the same spindle
component density. Consistent with
limited components scaling spindle
size with cell volume, Good et al. [1]
find that available tubulin
concentrations fall with decreasing
cell size (Figure 1, left droplet) while
spindle tubulin density remains
constant. While a mass conservation
model shows that tubulin depletion
could in principle account for
volume-dependent spindle scaling,
which components become limiting for
spindle size is not known at this time.
Finally, spindle size does not depend
on droplet volume in large volumes
where building blocks are in huge
excess, indicating that a factor other
than volume must set spindle size in
this regime.
Akin to man-made structures, both
intrinsic and extrinsic mechanisms
can set spindle size [10,11], each
dominating in different regimes.
Intrinsic mechanisms set an upper
limit for spindle size in the large
droplet regime (and in unbounded
extract), and extrinsic ones set
spindle size in the small droplet
regime. A major future challenge will
be to understand how these
mechanisms integrate together,
and how a scale for spindle length
emerges. Intrinsic cues are
programmed by the molecular
composition of the cytoplasm, either
its building blocks or building
tools — as for snow forts. For example,
spindle size could be set by a
morphogen gradient around
chromosomes, motors that create
position-dependent forces, or a
structural scaffold of a given length.
Indeed, developmental changes in the
molecular composition of the
cytoplasm can affect the spindle size
vs droplet volume relationship [1].
How molecular composition affects
spindle size is not understood, but
key players are emerging
[6,8,11,13–17]. In contrast, extrinsic
cues come from the environment, as for
LEGO structures. While intrinsic cues
have historically dominated the
discussion, the work by Good et al. [1]
and Hazel et al. [2] demonstrates for thefirst time that cell volume can directly
control spindle size—and pushes us to
examine a possible role for other
extrinsic cues. Extrinsic cues can
serve to tune spindle size in cases
where the nature of the cytoplasm is
the same, but cell size changes;
complementarily, intrinsic cues can
serve to tune spindle size in cases
where cell volume does not change, but
developmental stage does. Thus, by
integrating different cues spindle size
can respond and adapt to key
molecular and physical changes in a
cells’ life.
The two new studies discussed
here [1,2] beg the question of how
volume affects the scaling of
intracellular structures, and provide
significant technical and conceptual
advances to move it forward. On a
technical front, the robust ability to
tune and control compartment
volumes for spindle assembly
reactions will allow us to
mechanistically dissect how volume
affects spindle size and architecture.
We do not know what component
(and it may be many) limits spindle
assembly in smaller volumes, and
depletion experiments in droplets
should inform on molecular
contributions to the scaling of
spindle size with cytoplasmic volume.
At a most basic level, to understand
how volume changes give rise to
spindle size changes, we will need to
know how spindle architecture is
altered in different volumes: we must
measure key parameters such as
microtubule length, density,
dynamics, and nucleation [18] in
droplets of different sizes formed
with the same cytoplasm. On a
conceptual front, the observation
that cytoplasmic volume regulates
spindle size paves the way for us to
consider how simple physical
parameters such as cytoplasmic
volume and geometry broadly
influence the scaling and function of
organelles and other cellular
assemblies. Volume sensing based
on component limitation is a simple,
passive and robust scaling
mechanism, and as such may be
broadly employed [19,20].
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